515 related articles for article (PubMed ID: 18449063)
1. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
[TBL] [Abstract][Full Text] [Related]
4. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
Guven M; Bulut Y; Sezer T; Aladag I; Eyibilen A; Etikan I
Int J Pediatr Otorhinolaryngol; 2006 May; 70(5):915-23. PubMed ID: 16293317
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 20- versus 10-day antimicrobial treatment for acute otitis media.
Mandel EM; Casselbrant ML; Rockette HE; Bluestone CD; Kurs-Lasky M
Pediatrics; 1995 Jul; 96(1 Pt 1):5-13. PubMed ID: 7596722
[TBL] [Abstract][Full Text] [Related]
7. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled trial of antimicrobial treatment for acute otitis media.
Tähtinen PA; Laine MK; Huovinen P; Jalava J; Ruuskanen O; Ruohola A
N Engl J Med; 2011 Jan; 364(2):116-26. PubMed ID: 21226577
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Poachanukoon O; Kitcharoensakkul M
Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
[TBL] [Abstract][Full Text] [Related]
10. Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
Casellas JM; Israele V; Marín M; Ishida MT; Heguilen R; Soutric J; Arenoso H; Sibbald A; Stamboulian D
Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1225-33. PubMed ID: 16061111
[TBL] [Abstract][Full Text] [Related]
11. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Henry DC; Kapral D; Busman TA; Paris MM
Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
[TBL] [Abstract][Full Text] [Related]
12. Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis.
Courter JD; Baker WL; Nowak KS; Smogowicz LA; Desjardins LL; Coleman CI; Girotto JE
Ann Pharmacother; 2010 Mar; 44(3):471-8. PubMed ID: 20150506
[TBL] [Abstract][Full Text] [Related]
13. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
Feldman W; Sutcliffe T; Dulberg C
CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
[TBL] [Abstract][Full Text] [Related]
14. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
[TBL] [Abstract][Full Text] [Related]
16. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
[TBL] [Abstract][Full Text] [Related]
17. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
Sher L; Arguedas A; Husseman M; Pichichero M; Hamed KA; Biswas D; Pierce P; Echols R
Pediatr Infect Dis J; 2005 Apr; 24(4):301-8. PubMed ID: 15818288
[TBL] [Abstract][Full Text] [Related]
18. Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
Sáez-Llorens X; Rodriguez A; Arguedas A; Hamed KA; Yang J; Pierce P; Echols R
Pediatr Infect Dis J; 2005 Apr; 24(4):293-300. PubMed ID: 15818287
[TBL] [Abstract][Full Text] [Related]
19. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
[TBL] [Abstract][Full Text] [Related]
20. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
